Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2337/db22-0468 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Response to Comment on D'Addio et al. Immunogenicity and Safety of SARS-CoV-2 mRNA Vaccines in a Cohort of Patients With Type 1 Diabetes. Diabetes 2022;71:1800-1806.
Diabetes
September 2022
International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, Dipartimento di Scienze Biomediche e Cliniche L. Sacco, Università di Milano, Milan, Italy.
Reply to letter to the editor regarding "Use of DPP-4 inhibitors in patients with COVID-19".
Acta Diabetol
February 2021
International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, DIBIC L. Sacco, Università di Milano, Milan, Italy.
Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study.
Diabetes Care
December 2020
International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, Dipartimento di Scienze Biomediche e Cliniche L. Sacco, Università di Milano, Milan, Italy
Objective: Poor outcomes have been reported in patients with type 2 diabetes and coronavirus disease 2019 (COVID-19); thus, it is mandatory to explore novel therapeutic approaches for this population.
Research Design And Methods: In a multicenter, case-control, retrospective, observational study, sitagliptin, an oral and highly selective dipeptidyl peptidase 4 inhibitor, was added to standard of care (e.g.
Letter: prevalence and patterns of gastrointestinal symptoms in a large Western cohort of patients with COVID-19.
Aliment Pharmacol Ther
September 2020
Digestive Disease Center, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
This article is linked to Tian et al and Tian and Rong papers. To view these articles, visit https://doi.org/10.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!